|
gptkbp:instanceOf
|
gptkb:drug
gptkb:anticoagulant
|
|
gptkbp:activeIngredient
|
gptkb:heparin
|
|
gptkbp:administeredBy
|
subcutaneous injection
intravenous injection
|
|
gptkbp:affiliatedWith
|
glycosaminoglycan
|
|
gptkbp:antidote
|
gptkb:protamine_sulfate
|
|
gptkbp:ATCCode
|
gptkb:B01AB01
|
|
gptkbp:brand
|
gptkb:Heparin_Sodium_Injection
gptkb:Hep-Lock
|
|
gptkbp:CASNumber
|
9041-08-1
|
|
gptkbp:contraindication
|
active bleeding
history of heparin-induced thrombocytopenia
severe thrombocytopenia
|
|
gptkbp:discoveredIn
|
1935
|
|
gptkbp:eliminatedIn
|
renal
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
heparin sodium
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
varies (heterogeneous mixture)
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:regulates
|
gptkb:FDA
|
|
gptkbp:sideEffect
|
bleeding
thrombocytopenia
osteoporosis (with long-term use)
|
|
gptkbp:usedFor
|
prevention of blood clots
treatment of deep vein thrombosis
treatment of pulmonary embolism
|
|
gptkbp:usedIn
|
cardiac surgery
dialysis
venous thromboembolism prophylaxis
|
|
gptkbp:bfsParent
|
gptkb:Hep-Lock
|
|
gptkbp:bfsLayer
|
7
|